AI Evaluation Notes

The prediction stated that China would start dumping and aggressively pricing pharmaceutical products in key markets like the US in the near future. As of December 2025, there is evidence indicating that China is producing numerous drugs below market price, particularly active pharmaceutical ingredients (APIs), making it difficult for other companies to compete on cost. This directly aligns with the prediction of aggressive pricing and potential dumping practices.